These findings highlight the critical role of obesity-related inflammation in enhancing the aggressiveness of luminal breast cancer, suggesting that this environment may influence the expression of ESR2 as well as oxidative stress and mitochondrial biomarkers. This evidence concerns the gene ESR2 and obesity disorder.